Facial Aesthetic Medicine
Croma-Pharma GmbH is involved in clinical research focused on moderate and severe horizontal forehead lines, with attention to the treatment of visible facial aging in the upper face.
- Horizontal forehead lines
- Facial wrinkle treatment
- Upper facial aesthetics
The sponsor’s trial activity centers on the clinical evaluation of botulinum toxin use in aesthetic dermatology and facial line reduction.
Neuromuscular Modulation
Its research landscape includes therapeutic interest in neuromuscular function as it relates to temporary relaxation of targeted facial muscles involved in forehead line formation.
- Botulinum toxin therapy
- Muscle activity control
- Forehead muscle treatment
The sponsor’s work reflects a focus on injectable therapies used to address expression-related facial lines through localized muscle modulation.
Injectable Therapeutics
Croma-Pharma GmbH funds research in injectable aesthetic treatments, with emphasis on products designed for precise administration in facial soft tissue.
- LetibotulinumtoxinA
- Facial injection patterns
- Localized treatment delivery
The clinical interest lies in refining injectable options for aesthetic correction of upper-face lines.
Medical Aesthetics Safety and Efficacy
The sponsor’s clinical research also addresses safety and efficacy considerations in aesthetic medicine, particularly for treatments targeting forehead rhytides.
- Treatment response assessment
- Subject-reported outcomes
- Evaluator-based assessment
These studies support the clinical development of aesthetic interventions for facial line improvement in adult populations.
